Sale!

HOXA13 Gene Hand-Foot-Uterus Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The HOXA13 gene plays a crucial role in the development of limbs and the urogenital tract. Mutations in this gene are associated with Hand-Foot-Genital (HFG) Syndrome, a rare genetic disorder characterized by limb malformations and urogenital defects. The Hand-Foot-Uterus Syndrome Genetic Test is a specific diagnostic tool designed to identify mutations in the HOXA13 gene to confirm a diagnosis of HFG Syndrome. This test is particularly vital for families with a history of the condition or when symptoms suggestive of the syndrome are present in an individual.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient’s DNA to search for abnormalities in the HOXA13 gene. The process is meticulous, ensuring high accuracy and reliability in the results. At a cost of 4400 AED, the test is a critical step towards a definitive diagnosis, paving the way for appropriate management and counseling for affected individuals and their families. Early diagnosis through this genetic test can significantly improve the quality of life for those with HFG Syndrome, allowing for targeted interventions and informed family planning decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HOXA13 Gene Hand-foot-uterus syndrome Genetic Test

At DNA Labs UAE, we offer the HOXA13 Gene Hand-foot-uterus syndrome Genetic Test at a cost of 4400.0 AED.

Test Details

The HOXA13 gene is responsible for providing instructions to make a protein called homeobox A13, which plays a crucial role in the development of limbs, genitals, and other related structures in the body. Mutations in the HOXA13 gene can lead to a condition called Hand-foot-uterus syndrome (HFUS), also known as Hand-foot-genital syndrome.

HFUS is a rare genetic disorder characterized by limb abnormalities, such as missing or underdeveloped fingers or toes, and malformation of the uterus in females. Other features may include abnormalities of the feet, such as fusion of the bones or missing toes, as well as genital abnormalities in both males and females.

Next-generation sequencing (NGS) genetic testing is a method used to analyze the DNA sequence of genes, including the HOXA13 gene. This test can detect mutations or changes in the gene that may be responsible for causing HFUS. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive genetic analysis.

By performing an NGS genetic test for the HOXA13 gene, doctors can confirm the diagnosis of HFUS and provide appropriate genetic counseling and management for affected individuals and their families. This information can also be used to understand the inheritance pattern of the condition and assess the risk of recurrence in future pregnancies.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre Test Information

Before undergoing the HOXA13 Gene Hand-foot-uterus syndrome Genetic Test, it is important to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with HOXA13 Gene Hand-foot-uterus syndrome NGS Genetic DNA Test gene HOXA13.

Test Name HOXA13 Gene Hand-foot-uterus syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for HOXA13 Gene Hand-foot-uterus syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with HOXA13 Gene Hand-foot-uterus syndrome NGS Genetic DNA Test gene HOXA13
Test Details

The HOXA13 gene is responsible for providing instructions to make a protein called homeobox A13, which plays a crucial role in the development of limbs, genitals, and other related structures in the body. Mutations in the HOXA13 gene can lead to a condition called Hand-foot-uterus syndrome (HFUS), also known as Hand-foot-genital syndrome.

HFUS is a rare genetic disorder characterized by limb abnormalities, such as missing or underdeveloped fingers or toes, and malformation of the uterus in females. Other features may include abnormalities of the feet, such as fusion of the bones or missing toes, as well as genital abnormalities in both males and females.

Next-generation sequencing (NGS) genetic testing is a method used to analyze the DNA sequence of genes, including the HOXA13 gene. This test can detect mutations or changes in the gene that may be responsible for causing HFUS. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive genetic analysis.

By performing an NGS genetic test for the HOXA13 gene, doctors can confirm the diagnosis of HFUS and provide appropriate genetic counseling and management for affected individuals and their families. This information can also be used to understand the inheritance pattern of the condition and assess the risk of recurrence in future pregnancies.